Alaunos Therapeutics, Inc. Employee Benefit and Share-based Payment Arrangement, Noncash
Alaunos Therapeutics, Inc. (TCRT) reported Employee Benefit and Share-based Payment Arrangement, Noncash of $113.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:EmployeeBenefitsAndShareBasedCompensationNoncash · last filed 2026-08-14
- Alaunos Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for the quarter ending 2026-06-30 was $57.00K, a 69.02% decline year-over-year.
- Alaunos Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for the quarter ending 2026-03-31 was $56.00K, a 17.65% decline year-over-year.
- Alaunos Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for the quarter ending 2025-12-31 was $35.00K, a 56.79% decline year-over-year.
- Alaunos Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for the quarter ending 2025-09-30 was $127.00K, a 58.75% increase year-over-year.
- Alaunos Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for fiscal 2025 was $414.00K, a 4.83% decline from fiscal 2024.
- Alaunos Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for fiscal 2024 was $435.00K, a 84.46% decline from fiscal 2023.
- Alaunos Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for fiscal 2023 was $2.80M, a 20.63% decline from fiscal 2022.
- Alaunos Therapeutics, Inc. employee benefit and share-based payment arrangement, noncash for fiscal 2022 was $3.53M, a 67.25% decline from fiscal 2021.
| Period end | Employee Benefit and Share-based Payment Arrangement, Noncash 3 month | Employee Benefit and Share-based Payment Arrangement, Noncash 6 month | Employee Benefit and Share-based Payment Arrangement, Noncash 9 month | Employee Benefit and Share-based Payment Arrangement, Noncash 12 month |
|---|---|---|---|---|
| 2026-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $113.00K 10-Q · filed 2026-08-14 | $148.00K derived: sum of 3 quarters · filed 2026-08-14 | $275.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $56.00K 10-Q · filed 2026-05-15 | $91.00K derived: sum of 2 quarters · filed 2026-05-15 | $218.00K derived: sum of 3 quarters · filed 2026-05-15 | $402.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $35.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $162.00K derived: sum of 2 quarters · filed 2026-03-31 | $346.00K derived: sum of 3 quarters · filed 2026-08-14 | $414.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $127.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $311.00K derived: sum of 2 quarters · filed 2026-08-14 | $379.00K 10-Q · filed 2025-11-14 | $460.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $184.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $252.00K 10-Q · filed 2026-08-14 | $333.00K derived: sum of 3 quarters · filed 2026-08-14 | $413.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $68.00K 10-Q · filed 2026-05-15 | $149.00K derived: sum of 2 quarters · filed 2026-05-15 | $229.00K derived: sum of 3 quarters · filed 2026-05-15 | $331.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $81.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $161.00K derived: sum of 2 quarters · filed 2026-03-31 | $263.00K derived: sum of 3 quarters · filed 2026-03-31 | $435.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $182.00K derived: sum of 2 quarters · filed 2025-11-14 | $354.00K 10-Q · filed 2025-11-14 | $604.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $102.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $274.00K 10-Q · filed 2025-08-14 | $524.00K derived: sum of 3 quarters · filed 2025-08-14 | $1.25M derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $172.00K 10-Q · filed 2025-05-15 | $422.00K derived: sum of 2 quarters · filed 2025-05-15 | $1.15M derived: sum of 3 quarters · filed 2025-05-15 | $2.06M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $976.00K derived: sum of 2 quarters · filed 2025-03-31 | $1.89M derived: sum of 3 quarters · filed 2025-03-31 | $2.80M 10-K · filed 2025-03-31 |
| 2023-09-30 | $726.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.64M derived: sum of 2 quarters · filed 2024-11-14 | $2.55M 10-Q · filed 2024-11-14 | $3.43M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $914.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $1.82M 10-Q · filed 2024-08-14 | $2.70M derived: sum of 3 quarters · filed 2024-08-14 | $3.51M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $910.00K 10-Q · filed 2024-05-15 | $1.79M derived: sum of 2 quarters · filed 2024-05-15 | $2.60M derived: sum of 3 quarters · filed 2024-05-15 | $3.58M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $877.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.69M derived: sum of 2 quarters · filed 2024-04-01 | $2.67M derived: sum of 3 quarters · filed 2024-04-01 | $3.53M 10-K · filed 2024-04-01 |
| 2022-09-30 | $808.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.80M derived: sum of 2 quarters · filed 2023-11-14 | $2.65M 10-Q · filed 2023-11-14 | $3.57M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $990.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.84M 10-Q · filed 2023-08-14 | $2.76M derived: sum of 3 quarters · filed 2023-08-14 | $5.13M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $853.00K 10-Q · filed 2023-05-10 | $1.77M derived: sum of 2 quarters · filed 2023-05-10 | $4.14M derived: sum of 3 quarters · filed 2023-05-10 | $9.43M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $917.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $3.29M derived: sum of 2 quarters · filed 2023-03-07 | $8.58M derived: sum of 3 quarters · filed 2023-03-07 | $10.77M 10-K · filed 2023-03-07 |
| 2021-09-30 | $2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $7.66M derived: sum of 2 quarters · filed 2022-11-14 | $9.86M 10-Q · filed 2022-11-14 | $11.29M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $5.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $7.49M 10-Q · filed 2022-08-15 | $8.92M derived: sum of 3 quarters · filed 2022-08-15 | $10.71M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $2.20M 10-Q · filed 2022-05-16 | $3.63M derived: sum of 2 quarters · filed 2022-05-16 | $5.42M derived: sum of 3 quarters · filed 2022-05-16 | $7.09M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $3.23M derived: sum of 2 quarters · filed 2022-03-30 | $4.89M derived: sum of 3 quarters · filed 2022-03-30 | $6.83M 10-K · filed 2022-03-30 |
| 2020-09-30 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $3.45M derived: sum of 2 quarters · filed 2021-11-08 | $5.39M 10-Q · filed 2021-11-08 | $6.99M derived: sum of 4 quarters · filed 2021-11-08 |
| 2020-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $3.60M 10-Q · filed 2021-08-13 | $5.20M derived: sum of 3 quarters · filed 2021-08-13 | $6.69M derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $1.94M 10-Q · filed 2021-05-06 | $3.54M derived: sum of 2 quarters · filed 2021-05-06 | $5.03M derived: sum of 3 quarters · filed 2021-05-06 | $7.83M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $3.09M derived: sum of 2 quarters · filed 2021-03-01 | $5.88M derived: sum of 3 quarters · filed 2021-03-01 | $7.34M 10-K · filed 2021-03-01 |
| 2019-09-30 | $1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.29M derived: sum of 2 quarters · filed 2020-11-05 | $5.74M 10-Q · filed 2020-11-05 | $6.42M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $4.25M 10-Q · filed 2020-08-06 | $4.94M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2019-03-31 | $1.46M 10-Q · filed 2020-05-07 | $2.14M derived: sum of 2 quarters · filed 2021-03-01 | ||
| 2018-12-31 | $684.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $7.53M 10-K · filed 2021-03-01 | ||
| 2018-09-30 | $6.85M 10-Q · filed 2019-11-07 | |||
| 2017-12-31 | $8.45M 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |